Kenneth R. Hess

62.8k total citations · 14 hit papers
509 papers, 41.8k citations indexed

About

Kenneth R. Hess is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kenneth R. Hess has authored 509 papers receiving a total of 41.8k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Oncology, 175 papers in Pulmonary and Respiratory Medicine and 127 papers in Cancer Research. Recurrent topics in Kenneth R. Hess's work include Glioma Diagnosis and Treatment (87 papers), Cancer Genomics and Diagnostics (58 papers) and Brain Metastases and Treatment (45 papers). Kenneth R. Hess is often cited by papers focused on Glioma Diagnosis and Treatment (87 papers), Cancer Genomics and Diagnostics (58 papers) and Brain Metastases and Treatment (45 papers). Kenneth R. Hess collaborates with scholars based in United States, China and France. Kenneth R. Hess's co-authors include Joseph S. Coselli, Hazim J. Safi, E. Stanley Crawford, Lars G. Svensson, Raymond Sawaya, Gabriel N. Hortobágyi, Lajos Pusztai, James L. Abbruzzese, W. Fraser Symmans and Frederick F. Lang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and JAMA.

In The Last Decade

Kenneth R. Hess

499 papers receiving 40.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

2001 2.3k citations Frederick F. Lang, Kenneth R. Hess et al. profile →
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

2008 2.2k citations Cornelia Liedtke, Chafika Mazouni et al. Journal of Clinical Oncology profile →
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

2009 1.8k citations Kenneth R. Hess, Frederick F. Lang et al. profile →
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

2017 1.4k citations Kenneth R. Hess et al. profile →
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

2005 1.4k citations Roman Rouzier, Charles M. Perou et al. Clinical Cancer Research profile →
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

2004 1.3k citations Lee M. Ellis, Kenneth R. Hess et al. profile →
Experience with 1509 patients undergoing thoracoabdominal aortic operations

1993 931 citations Kenneth R. Hess et al. profile →
Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

1999 722 citations Kenneth R. Hess et al. Journal of Clinical Oncology profile →
Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients

1986 639 citations Kenneth R. Hess et al. profile →
Metastatic patterns in adenocarcinoma

2006 636 citations Kenneth R. Hess et al. Cancer profile →
Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients

1986 621 citations Kenneth R. Hess et al. profile →
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

2006 553 citations Kenneth R. Hess, K. Anderson et al. Journal of Clinical Oncology profile →
Deep hypothermia with circulatory arrest. Determinants of stroke and early mortality in 656 patients.

1993 466 citations Kenneth R. Hess et al. profile →
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

2015 456 citations Kenneth R. Hess et al. profile →

Peers

Countries citing papers authored by Kenneth R. Hess

Since Specialization

Citations

This map shows the geographic impact of Kenneth R. Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth R. Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth R. Hess more than expected).

Fields of papers citing papers by Kenneth R. Hess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth R. Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth R. Hess. The network helps show where Kenneth R. Hess may publish in the future.

Co-authorship network of co-authors of Kenneth R. Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth R. Hess. A scholar is included among the top collaborators of Kenneth R. Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth R. Hess. Kenneth R. Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer	Journal of Clinical Oncology	Cornelia Liedtke, Chafika Mazouni et al.	62
2	Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial	Clinical Cancer Research	Vivek Subbiah, Pete Anderson et al.	32
3	Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer	Clinical Cancer Research	Kenneth R. Hess, Filip Jankú et al.	40
4	Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition	Clinical Cancer Research	Xian Chen, Angela Alexander et al.	78
5	Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs	Clinical Cancer Research	Diogo Diniz Gomes Bugano, Kenneth R. Hess et al.	17
6	Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act	Clinical Cancer Research	Kenneth L. Kehl, Siqing Fu et al.	4
7	Phase 1 Study of Spinal Cord Constraint Relaxation with Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients with Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression	International Journal of Radiation OncologyBiologyPhysics	Amol J. Ghia, Kenneth R. Hess et al.	4
8	TIE2 Associates with Caveolae and Regulates Caveolin-1 To Promote Their Nuclear Translocation	Molecular and Cellular Biology	Mohammad B. Hossain, Jingyi Li et al.	13
9	Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells	Clinical Cancer Research	Chad Tang, James W. Welsh et al.	251
10	Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual	Clinical Cancer Research	Chad Tang, Kenneth R. Hess et al.	9
11	Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials	Clinical Cancer Research	Ying Yuan, Kenneth R. Hess et al.	131
12	Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic	Clinical Cancer Research	Denis L. Jardim, Chad Tang et al.	65
13	Synergy Between VEGF/VEGFR Inhibitors and Chemotherapy Agents in the Phase I Clinic	Clinical Cancer Research	Chad Tang, Kenneth R. Hess et al.	11
14	Predictive Value of Phase I Trials for Safety in Later Trials and Final Approved Dose: Analysis of 61 Approved Cancer Drugs	Clinical Cancer Research	Denis L. Jardim, Kenneth R. Hess et al.	39
15	Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer	Clinical Cancer Research	Adel Tabchy, Vicente Valero et al.	160
16	Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy	Molecular Cancer Therapeutics	Stacy Moulder, Kai Yan et al.	27
17	Reproducibility of Gene Expression Signature–Based Predictions in Replicate Experiments	Clinical Cancer Research	K. Anderson, Kenneth R. Hess et al.	22
18	Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy breakdown →	Clinical Cancer Research	Roman Rouzier, Charles M. Perou et al.	1414
19	Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma	Cancer	W. Fraser Symmans, Mark Ayers et al.	140
20	Extensions and Applications of Event Charts	The American Statistician	J. Jack Lee, Kenneth R. Hess et al.	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact